-
-
-
-
-
-
-
Leerink Partners Downgrades Sucampo Pharmaceuticals (SCMP) to Market Perform Following Acquisition
-
-
-
-
-
-
-
Sucampo Pharma (SCMP) Discloses $44M Merger Termination Fee
-
-
-
-
-
-
-
Cancer Prevention Pharmaceuticals Receives $9.5 Million in Additional Funding from Sucampo Following Phase 3 Trial Progress
-
-
-
-
-
-
-
Sucampo Acquires Vtesse Inc.
-
-
-
-
-
-
-
Guggenheim Reiterates Buy on Sucampo Pharma (SCMP) Following 1Q Earnings
-
-
-
-
-
-
-
Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors
-
-
-
-
-
-
-
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
-
1,155,288 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

